- Nachrichtendetail
-
28.03.2024 12:06:41 - dpa-AFX: *GILEAD SCIENCES, XILIO THERAPEUTICS ANNOUNCE LICENSE AGREEMENT TO DEVELOP TUMOR-ACTIVATED IL-12 PROGRAM, XTX301
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Gilead Sciences | 885823 | NASDAQ | 69,405 | 26.06.24 20:36:30 | -0,205 | -0,29% | 69,400 | 69,410 | 70,640 | 69,610 |
